Charles Schwab Investment Management »

Generate Biomedicines Ord shares owned by Charles Schwab Investment Management

Quarter-by-quarter ownership of Generate Biomedicines Ord (GENB) shares owned by Charles Schwab Investment Management from 13F filings

Historical chart of Charles Schwab Investment Management investment in Generate Biomedicines Ord

Tip: Access up to 7 years of quarterly data

All positions including Generate Biomedicines Ord held by Charles Schwab Investment Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Generate Biomedicines Ord by Charles Schwab Investment Management

Quarter filed Position value Share count Share price at filing
2026-06-30 $3.8M 225k 16.87

More positions owned by Charles Schwab Investment Management

NVIDIA Corporation (NVDA)
Apple (AAPL)
Microsoft Corporation (MSFT)
Amazon (AMZN)
Alphabet Cap Stk Cl A (GOOGL)
Broadcom (AVGO)
Schwab Strategic Tr Fundamental Us L (FNDX)
Alphabet Cap Stk Cl C (GOOG)
Meta Platforms Cl A (META)
UnitedHealth (UNH)
Tesla Motors (TSLA)
Micron Technology (MU)
Schwab Strategic Tr Fundamental Intl (FNDF)
Eli Lilly & Co. (LLY)
Home Depot (HD)

View all positions for Charles Schwab Investment Management

Top funds holding Generate Biomedicines Ord

Flagship Ventures Management
FMR
Capital World Investors
Braidwell
T. Rowe Price Associates
Norges Bank Investment Management
Arch Venture Corp
HarbourVest Partners
BlackRock
Baker Bros. Advisors
Jpmorgan Chase & Co
Deep Track Capital
ARK Investment Management
Vanguard Capital Management
Harvard Management Company

View all funds holding Generate Biomedicines Ord